Scarica l'app Stockscreener
224.09
0.56%
1.24
Dopo l'orario di chiusura:
221.44
-2.65
-1.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Resmed Inc Borsa (RMD) Ultime notizie
Wealth Enhancement Advisory Services LLC Has $1.66 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Element Squared LLC Buys Shares of 6,067 ResMed Inc. $RMD - MarketBeat
Aberdeen Group Reduces Stake in ResMed Inc. - National Today
Aberdeen Group plc Sells 37,737 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. (NYSE:RMD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Insider Sell: Brett Sandercock Sells Shares of ResMed Inc (RMD) - GuruFocus
RESMED INC. R (RME.MU) Q1 FY2025 earnings call transcript - Yahoo Finance
Resmed CFO Sandercock sells $224k in stock By Investing.com - Investing.com South Africa
Resmed CFO Sandercock sells $224k in stock - Investing.com
ResMed (RMD) CFO Sandercock sells 1,000 shares in open market trade - Stock Titan
J. Safra Sarasin Holding AG Sells 10,794 Shares of ResMed Inc. $RMD - MarketBeat
Spire Wealth Management Cuts Stock Holdings in ResMed Inc. $RMD - MarketBeat
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
ResMed Inc. (RMD) stock price, news, quote and history - Yahoo Finance UK
ResMed Inc. (RMD.AX) stock price, news, quote and history - Yahoo Finance Singapore
Insider Selling: ResMed (NYSE:RMD) Director Sells 2,000 Shares of Stock - MarketBeat
ResMed Inc. (RMD) latest stock news and headlines - Yahoo Finance Singapore
Resmed director Farrell sells $450,000 in stock By Investing.com - Investing.com India
Resmed director Farrell sells $450,000 in stock - Investing.com
Resmed Insider Sold Shares Worth $450,000, According to a Recent SEC Filing - MarketScreener
ResMed (NYSE: RMD) director sells 2,000 shares under Rule 10b5-1 plan - Stock Titan
ResMed Inc. (RMD) Stock forecasts - Yahoo Finance UK
Peter C. Farrell (RMD) sells 6,000 shares via Rule 144 notices (NYSE: RMD) - Stock Titan
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 - The Manila Times
Resmed to post quarterly results after market close on April 30 - Stock Titan
Affiliate proposes three 1,000-share sales for RMD (NYSE: RMD) — broker listed - Stock Titan
ResMed Inc. stock rises Tuesday, still underperforms market - MarketWatch
Is It Time To Revisit ResMed (RMD) After Recent Share Price Weakness? - Yahoo Finance
ResMed (RMD) Valuation Check After Recent Share Price Weakness - Sahm
ResMed back on the Buy List - intelligentinvestor.com.au
ResMed Earnings Preview: What to Expect - Yahoo Finance
SG Americas Securities LLC Cuts Stock Position in ResMed Inc. $RMD - MarketBeat
Eagleford Energy and ResMed Compared - National Today
ResMed Inc. Stock: Navigating Sleep Apnea Market Leadership Amid Demographic Tailwinds and Digital I - AD HOC NEWS
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress - MSN
RBC Capital Maintains ResMed Inc.Depositary Receipt (RSMDF) Outperform Recommendation - MSN
ResMed stock price forecast: technical weakness persists as RMD struggles below key moving averages - Traders Union
Vanguard (RMD) disaggregates holdings; reports zero ownership in ResMed - Stock Titan
Regatta Capital Group LLC Invests $2.51 Million in ResMed Inc. - nationaltoday.com
Regatta Capital Group LLC Takes $2.51 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed & Netwealth: A Fresh Look at Valuation Trends - Kalkine Media
Dakota Wealth Management Has $8.18 Million Holdings in ResMed Inc. $RMD - MarketBeat
Assenagon Asset Management S.A. Has $19.43 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock outperforms market despite losses on the day - MarketWatch
ResMed Inc. stock: Leader in sleep and respiratory care with strong North American market presence - AD HOC NEWS
Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks - Yahoo Finance
Is ResMed stock underperforming the Nasdaq? - MSN
ResMed Inc. (RMD.AX) Alternative Data AnalyticsSocial & Digital Signals - Meyka
ResMed Inc stock faces pressure amid slowing sleep apnea device demand and insurance reimbursement h - AD HOC NEWS
ResMed Share Price Insights: Is RMD Worth Watching in 2026? - Kalkine Media
ResMed Inc. stock faces pressure amid weak performance and uncertain outlook in sleep apnea market - AD HOC NEWS
Research Alert: CFRA Lowers Rating On Shares Of Resmed Inc. To Hold From Buy - moomoo.com
ResMed (RMD) Downgraded by Baird, Price Target Lowered to $275 | - GuruFocus
Nordea Investment Management Boosts ResMed Stake by 37% - National Today
Nordea Investment Management AB Purchases 294,124 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock advances amid strong Q2 earnings and digital health push, drawing DACH investor in - AD HOC NEWS
ResMed (RMD) Valuation Check After Recent Share Price Pullback And Growth Expectations - Yahoo Finance
0.64%
1.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):